Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 188

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study

Open access
Abolghasemi, Hassan, Eshghi, Peyman, Cheraghali, Abdol Majid, Imani Fooladi, Abbas Ali, Bolouki Moghaddam, Farzaneh, Imanizadeh, Sina, Moeini Maleki, Matin, Ranjkesh, Mohammad, Rezapour, Mohammad, Bahramifar, Ali, Einollahi, Behzad, Hosseini, Mohammad Javad, Jafari, Nematollah Joneidi, Nikpouraghdam, Mohamad, Sadri, Nariman, Tazik, Mokhtar, Sali, Shanaz, Okati, Shamsi, Askari, Elham, Tabarsi, Payam, Aslani, Jafar, Sharifipour, Ehsan, Jarahzadeh, Mohammad Hossein, Khodakarim, Nastaran, Salesi, Mahmood, Jafari, Ramezan, Shahverdi, Samira · 2020 · Transfusion and Apheresis Science

Abstract

Since Dec. 2019 the new coronavirus (SARS-CoV-2) has infected millions and claimed life of several hundred thousand worldwide. However, so far no approved vaccine or drug therapy is available for treatment of virus infection. Convalescent plasma has been considered a potential modality for COVID-19 infection. One hundred eighty-nine COVID-19 positive patients including 115 patients in plasma therapy group and 74 patients in control group, registered in the hospitals with confirmed COVID-19 infection, entered this multi-center clinical study. Comparison of outcomes including all-cause mortality, total hospitalization days and patients’ need for intubation between the two patient groups shows that total of 98 (98.2 %) of patients who received convalescent plasma were discharged from hospital which is substantially higher compared to 56 (78.7 %) patients in control group. Length of hospitalization days was significantly lower (9.54 days) in convalescent plasma group compared with that of control group (12.88 days). Only 8 patients (7%) in convalescent plasma group required intubation while that was 20 % in control group. This clinical study provides strong evidence to support the efficacy of convalescent plasma therapy in COVID-19 patients and recommends this treatment for management of these patients. Clinical efficacy, immediate availability and potential cost effectiveness could be considered as main advantages of convalescent plasma therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.transci.2020.102875

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 188

Metadata

Authors
Abolghasemi, H., Eshghi, P., Cheraghali, A. M., Imani Fooladi, A. A., Bolouki Moghaddam, F., Imanizadeh, S., Moeini Maleki, M., Ranjkesh, M., Rezapour, M., Bahramifar, A., Einollahi, B., Hosseini, M. J., Jafari, N. J., Nikpouraghdam, M., Sadri, N., Tazik, M., Sali, S., Okati, S., Askari, E., Tabarsi, P., Aslani, J., Sharifipour, E., Jarahzadeh, M. H., Khodakarim, N., Salesi, M., Jafari, R., & Shahverdi, S.
Venue
Transfusion and Apheresis Science
Publisher
Elsevier BV
Published
2020-10
Volume
59
Issue
5
Pages
102875
ISSN
1473-0502 (ISSN-L)
OpenAlex
W3042487110
Cited by
188
References
2
FWCI
5.37
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study. https://app.cochat.ai/papers/10.1016/j.transci.2020.102875
The paper
Abolghasemi, H., Eshghi, P., Cheraghali, A. M., Imani Fooladi, A. A., Bolouki Moghaddam, F., Imanizadeh, S., Moeini Maleki, M., Ranjkesh, M., Rezapour, M., Bahramifar, A., Einollahi, B., Hosseini, M. J., Jafari, N. J., Nikpouraghdam, M., Sadri, N., Tazik, M., Sali, S., Okati, S., Askari, E., . . . Shahverdi, S. (2020). Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study. Transfusion and Apheresis Science. https://doi.org/10.1016/j.transci.2020.102875

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.